Finance

Lists
NATCOPHARM:NSE
Natco Pharma Ltd
₹ 822.00
+0.09%
(+0.70) 1D
10-р сарын 5, 15:30:00 (GMT+5:30)  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for NATCOPHARM...
Open
₹ 825.00
High
₹ 827.45
Low
₹ 801.40
Mkt. cap
147.32Т
Avg. vol.
433.95 мян
Volume
571.71 мян
Dividend
0.54%
Quarterly dividend
₹ 1.12
Ex-dividend date
2026 оны 8-р сарын 20
P/E ratio
12.97
52-wk high
₹ 1,216.89
52-wk low
₹ 785.65
EPS
₹ 63.37
Shares outstanding
182.26 сая
No. of employees
4 мян
Open
₹ 825.00
High
₹ 827.45
Low
₹ 801.40
Mkt. cap
147.32Т
Avg. vol.
433.95 мян
Volume
571.71 мян
Dividend
0.54%
Quarterly dividend
₹ 1.12
Ex-dividend date
2026 оны 8-р сарын 20
P/E ratio
12.97
52-wk high
₹ 1,216.89
52-wk low
₹ 785.65
EPS
₹ 63.37
Shares outstanding
182.26 сая
No. of employees
4 мян
News stories
From web sources and news partners
Profile
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations, active pharmaceutical ingredients and agrochemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs at affordable prices. Wikipedia
About Natco Pharma Ltd
CEORajeev Nannapaneni
Employees4.43 мян
Founded1981
HeadquartersBanjara Hills, Телангана, Энэтхэг
SectorPharmaceutical industry
Last report
2026 оны 8-р сарын 14
Fiscal period
Q1 2027
EPS / Est. (INR)
₹ 11.53 / ₹ 8.86
+30.06%beat
Revenue / Est. (INR)
7.35 тэрбум / 7.96 тэрбум
-7.66%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
13.63 тэрбум
6.47 тэрбум
7.43 тэрбум
7.35 тэрбум
Cost of goods sold
1.70 тэрбум
1.33 тэрбум
1.99 тэрбум
1.48 тэрбум
Cost of revenue
1.70 тэрбум
1.33 тэрбум
1.99 тэрбум
1.48 тэрбум
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.00 тэрбум
1.59 тэрбум
1.63 тэрбум
1.79 тэрбум
Operating expense
6.66 тэрбум
4.02 тэрбум
4.38 тэрбум
4.48 тэрбум
Total operating expenses
8.36 тэрбум
5.35 тэрбум
6.37 тэрбум
5.96 тэрбум
Operating income
5.27 тэрбум
1.12 тэрбум
1.06 тэрбум
1.39 тэрбум
Other non operating income
1.00 тэрбум
581.00 сая
-2.11 тэрбум
592.00 сая
EBT including unusual items
6.14 тэрбум
1.72 тэрбум
1.80 тэрбум
2.70 тэрбум
EBT excluding unusual items
6.14 тэрбум
1.72 тэрбум
2.02 тэрбум
2.70 тэрбум
Income tax expense
958.00 сая
207.00 сая
-892.00 сая
634.00 сая
Effective tax rate
15.61%
12.03%
-49.61%
23.49%
Other operating expenses
4.14 тэрбум
1.96 тэрбум
2.23 тэрбум
2.22 тэрбум
Net income
5.18 тэрбум
1.52 тэрбум
2.68 тэрбум
2.06 тэрбум
Net profit margin
38.03%
23.40%
36.08%
28.09%
Earnings per share
28.94
8.46
14.96
11.53
Interest and investment income
-
-
2.33 тэрбум
-
Interest expense
-131.00 сая
-95.00 сая
-
-130.00 сая
Net interest expenses
-131.00 сая
-95.00 сая
2.33 тэрбум
-130.00 сая
Depreciation and amortization charges
524.00 сая
462.00 сая
504.00 сая
471.00 сая
EBITDA
5.82 тэрбум
1.57 тэрбум
1.55 тэрбум
1.91 тэрбум
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google аппс